MIDD Webinar Series | Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and  Novartis perspectives on this Model Informed Drug Development application

MIDD Webinar Series | Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis perspectives on this Model Informed Drug Development application

Includes a Live Web Event on 03/19/2025 at 12:00 PM (EDT)

The MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.

Key:

Complete
Failed
Available
Locked
MIDD Series: Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis perspectives on this Model Informed Drug Development application
03/19/2025 at 12:00 PM (EDT)  |  60 minutes
03/19/2025 at 12:00 PM (EDT)  |  60 minutes